Infliximab and anti-Infliximab antibody-13579

Test info

  
Infliximab and anti-Infliximab antibody
  
13579
  
LAB13579
  
INFLIXIMAB
  
Anti-TNF-alpha drug
IFD
Remicade
  
Infliximab drug level, anti-infliximab antibody and serial monitoring
  

Provides infliximab drug concentration levels as well as levels of anti-infliximab antibodies.

Specimen

  
Serum
  
  
2.0 mL
  
1.0 mL

Submission of the minimum volume does not allow for repeat testing
  

Immediatley following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
  4. Freeze
  
  
  1. Allow sample to clot
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
  4. Freeze
  

Frozen (preferred) - 359 days

Freeze/thaw cycle: stable x6

Refrigerated - 7 days

Ambient - 7 days

 

Performance

  
Esoterix Endocrinology (803870) via LabCorp (503870): R-LC
  
2x/wk
  
5 - 10 days
  

Electrochemiluminescence Immunoassay (ECLIA)

Clinical and Interpretive info

  

An interpretive report will be provided

Billing

  
82397
80230
  
Result 39803-2

Tracking

  
04/08/2019
  
12/20/2023
  
12/20/2023